Summary of findings 11. Enoximone compared to epinephrine‐nitroglycerine for low cardiac output syndrome.

Enoximone compared with epinephrine‐nitroglycerine for low cardiac output syndrome
Patient or population: adults with low cardiac output syndrome Settings: hospital Intervention: enoximone Comparison: epinephrine‐nitroglycerine
Outcomes	Anticipated absolute effects (95% CI)		Relative effect (95% CI)	No of Participants (studies)	Quality of the evidence (GRADE)	Comments
	Risk with epinephrine‐nitroglycerine	Risk with enoximone
All‐cause mortality	Outcome not reported in any of the included studies.
*The basis for the assumed risk (e.g. the median control group risk across studies) is provided in footnotes. The corresponding risk (and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the intervention (and its 95% CI). CI: Confidence interval; LCOS: low cardiac output syndrome; RR: Risk Ratio
GRADE Working Group grades of evidence High quality: Further research is very unlikely to change our confidence in the estimate of effect. Moderate quality: Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate. Low quality: Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate. Very low quality: We are very uncertain about the estimate.